Product Description
Cis-4,7,10,13,16,19-Docosa-Hexaenoic Acid
Application Notes
Cis-4,7,10,13,16,19-Docosahexaenoic Acid reduces amyloid β production whose accumulation has been found to be associated with the risk of Alzheimers . Maternal Docosahexaenoic Acid supplementation has been found to decrease lung inflammation in hyperoxia-exposed newborn mice. It also has potent antiinflammatory properties.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Receptor Agonist
Specifications
SKU | 02159097-CF |
Alternate Names | Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaneoic acid (22:6, n-3); DHA |
Application Notes | Cis-4,7,10,13,16,19-Docosahexaenoic Acid reduces amyloid β production whose accumulation has been found to be associated with the risk of Alzheimers . Maternal Docosahexaenoic Acid supplementation has been found to decrease lung inflammation in hyperoxia-exposed newborn mice. It also has potent antiinflammatory properties. |
Base Catalog Number | 159097 |
Beilstein Registry Number | 1715505 |
Biochemical Physiological Actions | DHA is a component of lipid membranes and the myelin sheath. DHA also serves as a precursor for signaling molecules such as prostaglandins and eicosanoids. |
CAS # | 6217-54-5 |
Format | Liquid |
Molecular Formula | C22H32O2 |
Molecular Weight | 328.496 g/mol |
Personal Protective Equipment | Eyeshields, Gloves, half-mask respirator, multi-purpose combination respirator cartridge |
Purity | ≥98% |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
Documents
Certificate of Analysis (COA)
Datasheet
Datasheet
Safety Data Sheets
English (United States)